Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07511491
NA
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
Sponsor: Tanta University
View on ClinicalTrials.gov
Summary
This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in cesarean section (CS).
Official title: Effect of Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section: A Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-04-10
Completion Date
2026-10-01
Last Updated
2026-04-06
Healthy Volunteers
No
Interventions
DRUG
Ondansetron lozenge
Patients will receive ondansetron lozenge 4 mg (Ondalenz ©), 2 hours before surgery.
DRUG
Ondansetron intravenous
Patients will receive 8 mg of ondansetron IV just before the surgery.
Locations (1)
Tanta University
Tanta, El-Gharbia, Egypt